Skip to content

Use of Virtual Reality to relieve anxiety and fear before medical consultation in Pediatric Oncology: a randomized clinical trial

Evaluation of the usability of a Virtual Reality Tool in the distraction of children and adolescents with Cancer during venous puncture

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-8rp76n4
Enrollment
Unknown
Registered
2024-10-11
Start date
2023-01-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Virtual Reality Exposure Therapy

Interventions

This study is a randomized, two-arm clinical trial without masking. Randomization was performed through the RedCap platform, with supervision of the hospital statisticians. After informed consent, ran

Sponsors

Hospital de Amor Infantojuvenil de Barretos
Lead Sponsor
Hospital de Amor Infantojuvenil de Barretos
Collaborator
Hospital do Câncer de Barretos - Fundação Pio XII
Collaborator

Eligibility

Age
7 Years to 16 Years

Inclusion criteria

Inclusion criteria: Patients between 7 and 16 years old; both sexes; who had their first appointment scheduled on an outpatient basis

Exclusion criteria

Exclusion criteria: Patients with visual and/or hearing deficits; patients with sensitivity to light; children with clinical conditions of nausea or vomiting when visually stimulated or very exacerbated at the time; patients with external shunts that prevent the use of the tool; patients with tumors in the head and neck region that are obstructive; patient diagnosed with epilepsy; patient or companion with cognitive impairment clinically assessed by the research team (impediment to completing the questionnaires and using the tool); patients who express anticipatory conditional generalized anxiety or untreated panic attacks; patients with clinical diagnoses of mental changes without pharmacological treatment assessed as impediment by the researcher; patients with a clinical diagnosis of Organic Brain Syndrome due to neurotoxicity (already treated or with some impeding deficit); Furthermore, if the researcher, when inviting the patient to the research, noticed that he was in intense pain and in need of medication intervention, she excluded the patient from the research and referred him to the Outpatient Intercurrence Center so that he could receive medical intervention

Design outcomes

Primary

MeasureTime frame
Expected outcome 1: reduction in pain and anxiety in patients using virtual reality glasses;Outcome found 1: A statistically significant decrease in pre-medical consultation anxiety was observed, in addition to a decrease in pain in the perception of parents and companions

Secondary

MeasureTime frame
No secondary outcomes were expected.

Countries

Brazil

Contacts

Public ContactVânea Silva

Hospital de Amor Infantojuvenil de Barretos

vanealuciass@gmail.com+55-17-981275709

Outcome results

None listed

Source: REBEC (via WHO ICTRP)